The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial.
Background: Salsalate, a nonacetylated prodrug of salicylate, has been shown to decrease blood glucose concentration in small studies.Objective: To compare the efficacy and safety of salsalate at different doses in patients with type 2 diabetes.Design: Parallel randomized trial with computer-generat...
| Publicado en: | Annals of Internal Medicine Vol. 152; no. 6; pp. 346 - 358 |
|---|---|
| Autores principales: | , , , , , , , , , , , |
| Formato: | clinical trial research Journal Article |
| Publicado: |
American College of Physicians
3/16/2010
|
| Acceso en línea: | Ver este registro en EBSCOhost |